Authors: John Yuk Ching Ting
Objectives: We utilize a Case Report of severe acute respiratory distress syndrome (ARDS) from pneumonia together with applications from Fic-Fac Ratio to creatively explain COVID-19's drug and vaccine developments, and mitigation measures to combat the resulting pandemic (declared by World Health Organization on March 11, 2020). Methods: Diagnostic test 'Accuracy' refers to ability of that test to distinguish between patients with disease, and those without. Our novel Fic-Fac Ratio, which is an acronym that stands for Fictitious-Factitious Ratio, is roughly considered as 'Inverse Accuracy' with higher Accuracy corresponding to lower Fic-Fac Ratio and vice versa. Regarded as tertiary spin-off from mathematically proving open problems in Number theory of Riemann hypothesis (and explaining two types of Gram points), Polignac's and Twin prime conjectures; we succinctly outline the derivation of this Ratio. Results: 2003 Case Report of 43 year-old male presenting with severe ARDS due to Bilateral Early Lobar Pneumonia of uncertain viral etiology resulting in death at a small Australian regional hospital. ACE is an acronym that stands for angiotensin-converting enzyme. The functions of ACE and its counterpart ACE2 are outlined. Physiological and pharmacological implications of ACE2 also acting as entry receptor for the coronavirus causing COVID-19 infection are detailed. Epidemiological principles on modelling COVID-19 pandemic with 'less accurate' SIR model versus 'more accurate' SEIR model are also presented. Conclusions: Controlling COVID-19 pandemic and developing effective COVID-19 drugs and vaccine(s) can be creatively explained using Fic-Fac Ratio. International collaboration is generally required to defeat COVID-19.
Comments: 14 Pages. Case Report of 43 year-old man with severe ARDS from pneumonia together with applications from Fic-Fac Ratio to creatively explain COVID-19’s drug and vaccine developments, and mitigation measures to combat the resulting pandemic.
Download: PDF
[v1] 2020-08-11 23:41:28
[v2] 2020-08-23 18:36:24
[v3] 2020-08-24 21:40:47
[v4] 2020-08-25 23:00:07
[v5] 2020-08-26 21:07:06
[v6] 2020-09-05 09:40:33
[v7] 2020-10-08 08:32:04
Unique-IP document downloads: 1095 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.